ArticleBreast cancer research and treatment2025

Oncotype DX recurrence score in node-positive patients in the post-RxPONDER era: a single-institution experience.

Rachel Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.